Streptokinase biosimilar (Bharat Serums & Vaccines)

链激酶生物类似药 (Bharat Serums & Vaccines)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStreptokinase biosimilar (Bharat Serums & Vaccines)
Drug Alias Name链激酶生物仿制药 (Bharat Serums & Vaccines)Thromboflux
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsVenous ThrombosisCoronary ThrombosisStroke +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBharat Serums And Vaccines Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsVenous ThrombosisCoronary ThrombosisStroke +[4
Inactive IndicationsN/A

Other Information

ATC CodeB01AD01
Related LinksN/A